Spots Global Cancer Trial Database for Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis
Official Title: Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis
Study ID: NCT00237159
Interventions
Study Description
Brief Summary: It is the aim of this clinical study to evaluate the skeletal-related event rate and tolerability of zoledronic acid in patients with prostate cancer patients and bone metastases.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
Contact Details
Name: Novartis Pharmaceuticals
Affiliation: Novartis Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
